Abstract:Bioactive peptides exhibit key roles in a wide variety of complex processes, such as regulation of body weight, learning, aging, and innate immune response. Next to the classical bioactive peptides, emerging from larger precursor proteins by specific proteolytic processing, a new class of peptides originating from small open reading frames (sORFs) have been recognized as important biological regulators. But their intrinsic properties, specific expression pattern and location on presumed non-coding regions have hindered the full characterization of the repertoire of bioactive peptides, despite their predominant role in various pathways. Although the development of peptidomics has offered the opportunity to study these peptides in vivo, it remains challenging to identify the full peptidome as the lack of cleavage enzyme specification and large search space complicates conventional database search approaches. In this study, we introduce a proteogenomics methodology using a new type of mass spectrometry instrument and the implementation of machine learning tools toward improved identification of potential bioactive peptides in the mouse brain. The application of trapped ion mobility spectrometry (tims) coupled to a time-of-flight mass analyzer (TOF) offers improved sensitivity, an enhanced peptide coverage, reduction in chemical noise and the reduced occurrence of chimeric spectra. Subsequent machine learning tools MS2PIP, predicting fragment ion intensities and DeepLC, predicting retention times, improve the database searching based on a large and comprehensive custom database containing both sORFs and alternative ORFs. Finally, the identification of peptides is further enhanced by applying the post-processing semi-supervised learning tool Percolator. Applying this workflow, the first peptidomics workflow combined with spectral intensity and retention time predictions, we identified a total of 167 predicted sORF-encoded peptides, of which 48 originating from presumed non-coding locations, next to 401 peptides from known neuropeptide precursors, linked to 66 annotated bioactive neuropeptides from within 22 different families. Additional PEAKS analysis expanded the pool of SEPs on presumed non-coding locations to 84, while an additional 204 peptides completed the list of peptides from neuropeptide precursors. Altogether, this study provides insights into a new robust pipeline that fuses technological advancements from different fields ensuring an improved coverage of the neuropeptidome in the mouse brain.

Probing Neuropeptide Signaling at the Organ and Cellular Domains Via Imaging Mass Spectrometry.

Mass spectral imaging and profiling of neuropeptides at the organ and cellular domains

Mass Spectrometric Imaging of Neuropeptides in Decapod Crustacean Neuronal Tissues.

Automated Mass Spectrometry Imaging of over 2000 Proteins from Tissue Sections at 100-Μm Spatial Resolution

High-Specificity Imaging Mass Spectrometry

Enhanced Coverage of Insect Neuropeptides in Tissue Sections by an Optimized Mass-Spectrometry-Imaging Protocol

Visualizing Neurotransmitters and Metabolites in the Central Nervous System by High Resolution and High Accuracy Mass Spectrometric Imaging

Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues

Correlative Imaging for Comprehensive Molecular Mapping of Individual Cell Types in Biological Tissues

Imaging mass spectrometry of isotopically-resolved intact proteins on a trapped ion-mobility quadrupole time-of-flight mass spectrometer

Imaging and quantification of neuropeptides in mouse pituitary tissue by atmospheric pressure matrix‐assisted laser desorption/ionization mass spectrometry

A brief review on mass/optical spectrometry for imaging analysis of biological samples

Imaging Mass Spectrometry (IMS) for drug discovery and development survey: Results on methods, applications and regulatory compliance

Ion Mobility Coupled to a Time-of-Flight Mass Analyzer Combined With Fragment Intensity Predictions Improves Identification of Classical Bioactive Peptides and Small Open Reading Frame-Encoded Peptides

Subcellular Mass Spectrometry Imaging and Absolute Quantitative Analysis Across Organelles.

EndoGenius: Optimized Neuropeptide Identification from Mass Spectrometry Datasets

Quantitative Mass Spectrometry Imaging: Therapeutics & Biomolecules

Spatial Proteomics by Trapped Ion Mobility supported MALDI MS/MS Imaging: A First Glance into Multiplexed and Spatial Peptide Identification

High spatial resolution imaging of biological tissues using nanospray desorption electrospray ionization mass spectrometry

MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology

Sample Preparation and Analysis for Imaging Mass Spectrometry